Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection

FASEB Journal

Volumn 24, Issue 1, 2010, Pages 218-228

  Assunção Miranda, Iranaia ^a   Amaral, Flavio A ^b   Bozza, Fernando A ^c   Fagundes, Caio T ^b   Sousa, Lirlandia P ^b   Souza, Danielle G ^b   Pacheco, Patrícia ^d   Barbosa Lima, Giselle ^d   Gomes, Rachel N ^d   Bozza, Patrícia T ^d   Da Poian, Andrea T ^a   Teixeira, Mauro M ^b   Bozza, Marcelo T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cytokine; Hemorrhagic fever; Inflammation; Lipid droplets; MIF; Sepsis

Indexed keywords

CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LETHALITY; LIVER CELL; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD;

ANIMALS; BASE SEQUENCE; CYTOKINES; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DISEASE MODELS, ANIMAL; DNA PRIMERS; GENE EXPRESSION; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION MEDIATORS; INTRAMOLECULAR OXIDOREDUCTASES; LEUKOCYTES; LIPID METABOLISM; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROSPECTIVE STUDIES;

ARTHROPODA; DENGUE VIRUS; MUS;

EID: 75149134774     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-139469     Document Type: Article

References (62)

1. Gibbons, R. V., and Vaughn, D. W. (2002) Dengue: an escalating problem. BMJ 324, 1563-1566
2. Guzman, M. G., and Kouri, G. (2002) Dengue: an update. Lancet Infect. Dis. 2, 33-42
3. Mackenzie, J. S., Gubler, D. J., and Petersen, L. R. (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10, S98-S109
4. Guzman, M. G., and Kouri, G. (2008) Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans. R. Soc. Trop. Med. Hyg. 102, 522-523
5. World Health Organization. (2002) Dengue and dengue hemorrhagic fever. Fact sheet 117/.2002. http://www.who.int/mediacentre/factsheets/fs117/en
6. Pan American Health Organization. (2007) Number of reported cases of dengue and dengue hemorrhagic fever (DHF), region of the Americas. http://www.paho.org/English/AD/DPC/CD/dengue-cases-2007.htm
7. Atrasheuskaya, A., Petzelbauer, P., Fredeking, T. M., and Ignatyev, G. (2003) Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol. Med. Microbiol. 35, 33-42
8. Souza, D. G., Fagundes, C. T., Sousa, L. P., Amaral, F. A., Souza, R. S., Souza, A. L., Kroon, E. G., Sachs, D., Cunha, F. Q., Bukin, E., Atrasheuskaya, A., Ignatyev, G., and Teixeira, M. M. (2009) Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc. Natl. Acad. Sci. U. S. A. 106, 14138-14143
9. Hober, D., Poli, L., Roblin, B., Gestas, P., Chungue, E., Granic, G., Imbert, P., Pecarere, J. L., Vergez-Pascal, R., Wattre, P., and Maniez-Montreuil, M. (1993) Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1 β (IL-1β) in dengue-infected patients. Am. J. Trop. Med. Hyg. 48, 324-331
10. Braga, E. L., Moura, P., Pinto, L. M., Ignacio, S. R., Oliveira, M. J., Cordeiro, M. T., and Kubelka, C. F. (2001) Detection of circulant tumor necrosis factor-α, soluble tumor necrosis factor p75 and interferon-γ in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem. Inst. Oswaldo Cruz 96, 229-232
11. Suharti, C., van Gorp, E. C., Setiati, T. E., Dolmans, W. M., Djokomoeljanto, R. J., Hack, C. E., ten Cate, H., and van der Meer, J. W. (2002) The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb. Haemost. 87, 42-46
12. Bosch, I., Xhaja, K., Estevez, L., Raines, G., Melichar, H., Warke, R. V., Fournier, M. V., Ennis, F. A., and Rothman, A. L. (2002) Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J. Virol. 76, 5588-5597
13. Green, S., and Rothman, A. L. (2006) Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 19, 429-436
14. Bozza, F. A., Cruz, O. G., Zagne, S. M., Azeredo, E. L., Nogueira, R. M., Assis, E. F., Bozza, P. T., and Kubelka, C. F. (2008) Multiplex cytokine profile from dengue patients: MIP-1 and IFN-γ as predictive factors for severity. BMC Infect. Dis. 8, 86-97
15. Chen, L. C., Lei, H. Y., Liu, C. C., Shiesh, S. C., Chen, S. H., Liu, H. S., Lin, Y. S., Wang, S. T., Shyu, H. W., and Yeh, T. M. (2006) Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hyg. 74, 142-147
16. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., and Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759
17. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71
18. Calandra, T., and Roger, T. (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800
19. Leng, L., and Bucala, R. (2005) Macrophage migration inhibitory factor. Crit. Care Med. 33, S475-477
20. Paiva, C. N., Arras, R. H., Magalhães, E. S., Alves, L. S., Lessa, L. P., Silva, M. H., Ejzemberg, R., Canetti, C., and Bozza, M. T. (2009) Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction. J. Leukoc. Biol. 85, 855-861
21. Bozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C., and David, J. R. (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341-346
22. Mitchell, R. A., Metz, C. N., Peng, T., and Bucala, R. (1999) Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 274, 18100-18106
23. Roger, T., David, J., Glauser, M. P., and Calandra, T. (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920-924
24. Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., and Bucala, R. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 99, 345-350
25. Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., Kooistra, T., Fingerle-Rowson, G., Ghezzi, P., Kleemann, R., McColl, S. R., Bucala, R., Hickey, M. J., and Weber, C. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596
26. Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., and Bucala, R. (2003) MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467-1476
27. Shi, X., Leng, L., Wang, T., Wang, W., Du, X., Li, J., McDonald, C., Chen, Z., Murphy, J. W., Lolis, E., Noble, P., Knudson, W., and Bucala, R. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606
28. Bozza, F. A., Gomes, R. N., Japiassú , A. M., Soares, M., Castro-Faria-Neto, H. C., Bozza, P. T., and Bozza, M. T. (2004) Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 22, 309-313
29. Sprong, T., Pickkers, P., Geurts-Moespot, A., van der Ven-Jongekrijg, J., Neeleman, C., Knaup, M., Leroy, D., Calandra, T., van der Meer, J. W., Sweep, F., and van Deuren, M. (2007) Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia. Shock 27, 482-487
30. Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hü ltner, L., Heumann, D., Männel, D., Bucala, R., and Glauser, M. P. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6, 164-170
31. Satoskar, A. R., Bozza, M., Rodriguez Sosa, M., Lin, G., and David, J. R. (2001) Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69, 906-911
32. McDevitt, M. A., Xie, J., Shanmugasundaram, G., Griffith, J., Liu, A., McDonald, C., Thuma. P., Gordeuk, V. R., Metz, C. N., Mitchell, R., Keefer, J., David, J., Leng, L., and Bucala, R. (2006) A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J. Exp. Med. 203, 1185-1196
33. Kimura, K., Nagaki, M., Nishihira, J., Satake, S., Kuwata, K., and Moriwaki, H. (2006) Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury. Clin. Vaccine Immunol. 13, 415-419
34. Arjona, A., Foellmer, H. G., Town, T., Leng, L., McDonald, C., Wang, T., Wong, S. J., Montgomery, R. R., Fikrig, E., and Bucala, R. (2007) Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 117, 3059-3066
35. Flores, M., Saavedra, R., Bautista, R., Viedma, R., Tenorio, E. P., Leng, L., Sánchez, Y., Juárez, I., Satoskar, A. A., Shenoy, A. S., Terrazas, L. I., Bucala, R., Barbi, J., Satoskar, A. R., and Rodriguez-Sosa, M. (2008) Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J. 22, 3661-3671
36. Magalhães, E. S., Paiva, C. N., Souza, H. S., Pyrrho, A. S., Mourão-Sá, D., Figueiredo, R. T., Vieira-de-Abreu, A., Dutra, H. S., Silveira, M. S., Gaspar-Elsas, M. I., Xavier-Elsas, P., Bozza, P. T., and Bozza, M. T. (2009) Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection. FASEB J. 23, 1262-1271
37. Souza, D. G., Soares, A. C., Pinho, V., Torloni, H., Reis, L. F., Teixeira, M. M., Dias, A. A., and Martins, M. T. (2002) Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury. Am. J. Pathol. 160, 1755-1765
38. Bozza, F. A., Salluh, J. I., Japiassu, A. M., Soares, M., Assis, E. F., Gomes, R. N., Bozza, M. T., Castro-Faria-Neto, H. C., and Bozza, P. T. (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit. Care 11, R49-R56
39. -ΔΔCT. Methods 25, 402-408
40. Zhang, W., Yue, B., Wang, G. Q., and Lu, S. L. (2002) Serum and ascites levels of macrophage migration inhibitory factor, TNF-α and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat. Dis. Int. 1, 577-580
41. Bozza, P. T., Magalhaes, K. G., and Weller, P. F. (2009) Leukocyte lipid bodies-biogenesis and functions in inflammation. Biochim. Biophys. Acta 1791, 40-51
42. Calandra, T., Bernhagen, J., Mitchell, R. A., and Bucala, R. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902
43. Chen, Y. C., and Wang, S. Y. (2002) Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J. Virol. 76, 9877-9887
44. Chen, S. T., Lin, Y. L., Huang, M. T., Wu, M. F., Cheng, S. C., Lei, H. Y., Lee, C. K., Chiou, T. W., Wong, C. H., and Hsieh, S. L. (2008) CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453, 672-676
45. Arndt, U., Wennemuth, G., Barth, P., Nain, M., Al-Abed, Y., Meinhardt, A., Gemsa, D., and Bacher, M. (2002) Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J. Virol. 76, 9298-9306
46. El-Bacha, T., Midlej, V., Pereira da Silva, A. P., Silva da Costa, L., Benchimol, M., Galina, A., and Da Poian, A. T. (2007) Mitochondrial and bioenergetic dysfunction in human hepatic cells infected with dengue 2 virus. Biochim. Biophys. Acta 1772, 1158-1166
47. Higa, L. M., Caruso, M. B., Canellas, F., Soares, M. R., Oliveira-Carvalho, A. L., Chapeaurouge, D. A., Almeida, P. M., Perales, J., Zingali, R. B., and Da Poian, A. T. (2008) Secretome of HepG2 cells infected with dengue virus: implications for pathogenesis. Biochim. Biophys. Acta 1784, 1607-1616
48. Umareddy, I., Tang, K. F., Vasudevan, S. G., Devi, S., Hibberd, M. L., and Gu, F. (2008) Dengue virus regulates type I interferon signalling in a strain-dependent manner in human cell lines. J. Gen. Virol. 89, 3052-3062
49. Lubetsky, J. B., Dios, A., Han, J., Aljabari, B., Ruzsicska, B., Mitchell, R., Lolis, E., and Al-Abed, Y. (2002) The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J. Biol. Chem. 277, 24976-24982
50. Pang, T., Cardosa, M. J., and Guzman, M. G. (2007) Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol. Cell Biol. 85, 43-45
51. Pacheco, P., Bozza, F. A., Gomes, R. N., Bozza, M., Weller, P. F., Castro-Faria-Neto, H. C., and Bozza, P. T. (2002) Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular loci involved in eicosanoid metabolism. J. Immunol. 169, 6498-6506
52. Flieger, O., Engling, A., Bucala, R., Lue, H., Nickel, W., and Bernhagen, J. (2003) Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett. 551, 78-86
53. Merk, M., Baugh, J., Zierow, S., Leng, L., Pal, U., Lee, S. J., Ebert, A. D., Mizue, Y., Trent, J. O., Mitchell, R., Nickel, W., Kavathas, P. B., Bernhagen, J., and Bucala, R. (2009) The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor. J. Immunol. 182, 6896-6906
54. Suzuki, T., Ogata, A., Tashiro, K., Nagashima, K., Tamura, M., Yasui, K., and Nishihira, J. (2000) Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF)mRNAin the mouse brain. Biochim. Biophys. Acta 1517, 100-106
55. Bacher, M., Eickmann, M., Schrader, J., Gemsa, D., and Heiske, A. (2002) Human cytomegalovirus-mediated induction of MIF in fibroblasts. Virology 299, 32-37
56. Armstrong, M. E., Gantier, M., Li, L., Chung, W. Y., McCann, A., Baugh, J. A., and Donnelly, S. C. (2008) Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism. J. Immunol. 180, 7125-7133
57. Frascaroli, G., Varani, S., Blankenhorn, N., Pretsch, R., Bacher, M., Leng, L., Bucala, R., Landini, M. P., and Mertens, T. (2009) Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J. Immunol. 182, 477-488
58. Assunção-Miranda, I., Bozza, M. T., and Da Poian, A. (2009) Pro-inflammatory response resulting from Sindbis virus infection of human macrophages: Implications for the pathogenesis of viral arthritis. J. Med. Virol. 82, 164-174
59. Koebernick, H., Grode, L., David, J. R., Rohde, W., Rolph, M. S., Mittrücker, H. W., and Kaufmann, S. H. (2002) Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 99, 13681-13686
60. Mizue, Y., Ghani, S., Leng, L., McDonald, C., Kong, P., Baugh, J., Lane, S. J., Craft, J., Nishihira, J., Donnelly, S. C., Zhu, Z., and Bucala, R. (2005) Role for macrophage migration inhibitory factor in asthma. Proc. Natl. Acad. Sci. U. S. A. 102, 14410-14415
61. Magalhães, E. S., Mourao-Sa, D. S., Vieira-de-Abreu, A., Figueiredo, R. T., Pires, A. L., Farias-Filho, F. A., Fonseca, B. P., Viola, J. P., Metz, C., Martins, M. A., Castro-Faria-Neto, H. C., Bozza, P. T., and Bozza, M. T. (2007) Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation. Eur. J. Immunol. 37, 1097-1106
62. Amin, M. A., Haas, C. S., Zhu, K., Mansfield, P. J., Kim, M. J., Lackowski, N. P., and Koch, A. E. (2006) Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFκB. Blood 107, 2252-2261